<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36148906</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1080-6059</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Emerging infectious diseases</Title><ISOAbbreviation>Emerg Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020-2021.</ArticleTitle><Pagination><StartPage>2027</StartPage><EndPage>2034</EndPage><MedlinePgn>2027-2034</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3201/eid2810.220847</ELocationID><Abstract><AbstractText>Environmental surveillance for poliovirus is increasingly used in poliovirus eradication efforts as a supplement to acute flaccid paralysis (AFP) surveillance. Environmental surveillance was officially established in 2017 in Senegal, where no poliovirus had been detected since 2010. We tested sewage samples from 2 sites in Dakar monthly for polioviruses. We identified a vaccine-derived poliovirus serotype 2 on January 19, 2021, from a sample collected on December 24, 2020; by December 31, 2021, we had detected 70 vaccine-derived poliovirus serotype 2 isolates circulating in 7 of 14 regions in Senegal. Sources included 18 AFP cases, 20 direct contacts, 17 contacts in the community, and 15 sewage samples. Phylogenetic analysis revealed the circulation of 2 clusters and provided evidence on the virus introduction from Guinea. Because novel oral polio vaccine serotype 2 was used for response activities throughout Senegal, we recommend expanding environmental surveillance into other regions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Faye</LastName><ForeName>Martin</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Kébé</LastName><ForeName>Ousmane</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Diop</LastName><ForeName>Boly</ForeName><Initials>B</Initials></Author><Author ValidYN="Y"><LastName>Ndiaye</LastName><ForeName>NDack</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Dosseh</LastName><ForeName>Annick</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Sam</LastName><ForeName>Abdoulaye</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Diallo</LastName><ForeName>Aliou</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Dia</LastName><ForeName>Hamet</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Diallo</LastName><ForeName>Jean Pierre</ForeName><Initials>JP</Initials></Author><Author ValidYN="Y"><LastName>Dia</LastName><ForeName>Ndongo</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Kiori</LastName><ForeName>Davy Evrard</ForeName><Initials>DE</Initials></Author><Author ValidYN="Y"><LastName>Diop</LastName><ForeName>Ousmane Madiagne</ForeName><Initials>OM</Initials></Author><Author ValidYN="Y"><LastName>Sall</LastName><ForeName>Amadou Alpha</ForeName><Initials>AA</Initials></Author><Author ValidYN="Y"><LastName>Faye</LastName><ForeName>Ousmane</ForeName><Initials>O</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Infect Dis</MedlineTA><NlmUniqueID>9508155</NlmUniqueID><ISSNLinking>1080-6040</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012722">Sewage</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004784" MajorTopicYN="N">Environmental Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012675" MajorTopicYN="N" Type="Geographic">Senegal</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012722" MajorTopicYN="N">Sewage</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Senegal</Keyword><Keyword MajorTopicYN="N">acute flaccid paralysis</Keyword><Keyword MajorTopicYN="N">environmental surveillance</Keyword><Keyword MajorTopicYN="N">polio</Keyword><Keyword MajorTopicYN="N">vaccine-derived poliovirus serotype 2</Keyword><Keyword MajorTopicYN="N">viruses</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>7</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36148906</ArticleId><ArticleId IdType="pmc">PMC9514370</ArticleId><ArticleId IdType="doi">10.3201/eid2810.220847</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pallansch M, Roos R. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, editors. Fields virology, 5th edition. Philadelphia: Lippincott Williams &amp; Wilkins; 2007. p. 839–93.</Citation></Reference><Reference><Citation>Khetsuriani N, Parashar UD. Enteric viral infections. In: Dale DC, Federman DD, editors. Scientific American medicine. New York: Web MD, Inc.; 2003. p. 1758–66.</Citation></Reference><Reference><Citation>Walker PJ, Siddell SG, Lefkowitz EJ, Mushegian AR, Adriaenssens EM, Alfenas-Zerbini P, et al. Changes to virus taxonomy and to the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2021). Arch Virol. 2021;166:2633–48. 10.1007/s00705-021-05156-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-021-05156-1</ArticleId><ArticleId IdType="pubmed">34231026</ArticleId></ArticleIdList></Reference><Reference><Citation>The Senegalese Ministry of Health and Social Action (MoHSAS). Technical guide for integrated disease monitoring of disease and response [In French]. June 2018.  [cited 2021 Dec 28]. https://www.sante.gouv.sn/sites/default/files/gudie%20national%20de%20la%20surveillance_1.pdf</Citation></Reference><Reference><Citation>Gast C, Bandyopadhyay AS, Sáez-Llorens X, De Leon T, DeAntonio R,, Jimeno J, et al. Fecal shedding of 2 novel live attenuated oral poliovirus type 2 vaccine candidates by healthy infants administered bivalent oral poliovirus vaccine/inactivated poliovirus vaccine: 2 randomized clinical trials. J Infect Dis. 2021. [Epub 2021 Oct 5].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9470102</ArticleId><ArticleId IdType="pubmed">34610135</ArticleId></ArticleIdList></Reference><Reference><Citation>Gumede N, Okeibunor J, Diop O, Baba M, Barnor J, Mbaye S, et al. Progress on the implementation of environmental surveillance in the African Region, 2011–2016. J Immunol Sci. 2018;24–30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6420122</ArticleId><ArticleId IdType="pubmed">30882093</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer TK, Simmonds P, Harvala H. The importance of enterovirus surveillance in a post-polio world. Lancet Infect Dis. 2022;22:e35–40. 10.1016/S1473-3099(20)30852-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30852-5</ArticleId><ArticleId IdType="pubmed">34265258</ArticleId></ArticleIdList></Reference><Reference><Citation>Pethani AS, Kazi Z, Nayyar U, Shafiq-Ur-Rehman M, Yousafzai MT, Ondrej M, et al. Poliovirus excretion among children with primary immune deficiency in Pakistan: a pilot surveillance study protocol. BMJ Open. 2021;11:e045904. 10.1136/bmjopen-2020-045904</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-045904</ArticleId><ArticleId IdType="pmc">PMC8319991</ArticleId><ArticleId IdType="pubmed">34321293</ArticleId></ArticleIdList></Reference><Reference><Citation>Gardner TJ, Diop OM, Jorba J, Chavan S, Ahmed J, Anand A. Surveillance to track progress toward polio eradication—worldwide, 2016–2017. MMWR Morb Mortal Wkly Rep. 2018;67:418–23. 10.15585/mmwr.mm6714a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6714a3</ArticleId><ArticleId IdType="pmc">PMC5898223</ArticleId><ArticleId IdType="pubmed">29649187</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba J, Diop OM, Iber J, Henderson E, Zhao K, Quddus A, et al. Update on vaccine-derived poliovirus outbreaks—worldwide, January 2018–June 2019. MMWR Morb Mortal Wkly Rep. 2019;68:1024–8. 10.15585/mmwr.mm6845a4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6845a4</ArticleId><ArticleId IdType="pmc">PMC6855511</ArticleId><ArticleId IdType="pubmed">31725706</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Guidelines for environmental surveillance of poliovirus circulation. WHO/V&amp;B/03.03. 2003.  [cited 2021 Dec 28]. https://apps.who.int/iris/handle/10665/67854</Citation></Reference><Reference><Citation>Ndiaye AK, Diop PAM, Diop OM. Environmental surveillance of poliovirus and non-polio enterovirus in urban sewage in Dakar, Senegal (2007-2013). Pan Afr Med J. 2014;19:243. 10.11604/pamj.2014.19.243.3538</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2014.19.243.3538</ArticleId><ArticleId IdType="pmc">PMC4377292</ArticleId><ArticleId IdType="pubmed">25848458</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Country office in Senegal: Senegal—virus tracking 2021–2022. Weekly report number 16: April 19, 2022. Dakar: The Organization; 2022.</Citation></Reference><Reference><Citation>WHO/Module3-Polio. Surveillance guide for vaccine-preventable diseases in the WHO South-East Asia Region [cited 2021 Oct 24]. https://apps.who.int/iris/handle/10665/277459</Citation></Reference><Reference><Citation>Kaundal N, Sarkate P, Prakash C, Rishi N. Environmental surveillance of polioviruses with special reference to L20B cell line. Virusdisease. 2017;28:383–9. 10.1007/s13337-017-0409-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13337-017-0409-1</ArticleId><ArticleId IdType="pmc">PMC5747842</ArticleId><ArticleId IdType="pubmed">29291229</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Polio Laboratory Manual. Website Department of Vaccines and Biologicals 2004.  [cited 2021 Dec 12]. https://apps.who.int/iris/handle/10665/68762</Citation></Reference><Reference><Citation>Kilpatrick DR, Yang CF, Ching K, Vincent A, Iber J, Campagnoli R, et al. Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J Clin Microbiol. 2009;47:1939–41. 10.1128/JCM.00702-09</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00702-09</ArticleId><ArticleId IdType="pmc">PMC2691077</ArticleId><ArticleId IdType="pubmed">19386844</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang CF, Naguib T, Yang SJ, Nasr E, Jorba J, Ahmed N, et al. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol. 2003;77:8366–77. 10.1128/JVI.77.15.8366-8377.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.15.8366-8377.2003</ArticleId><ArticleId IdType="pmc">PMC165252</ArticleId><ArticleId IdType="pubmed">12857906</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewardson AJ, Roberts JA, Beckett CL, Prime HT, Loh PS, Thorley BR, et al. Imported case of poliomyelitis, Melbourne, Australia, 2007. Emerg Infect Dis. 2009;15:63–5. 10.3201/eid1501.080791</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1501.080791</ArticleId><ArticleId IdType="pmc">PMC2660702</ArticleId><ArticleId IdType="pubmed">19116053</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalyaanamoorthy S, Minh BQ, Wong TKF, von Haeseler A, Jermiin LS. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat Methods. 2017;14:587–9. 10.1038/nmeth.4285</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4285</ArticleId><ArticleId IdType="pmc">PMC5453245</ArticleId><ArticleId IdType="pubmed">28481363</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifinopoulos J, Nguyen LT, von Haeseler A, Minh BQ. W-IQ-TREE: a fast online phylogenetic tool for maximum likelihood analysis. Nucleic Acids Res. 2016;44(W1):W232-5. 10.1093/nar/gkw256</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw256</ArticleId><ArticleId IdType="pmc">PMC4987875</ArticleId><ArticleId IdType="pubmed">27084950</ArticleId></ArticleIdList></Reference><Reference><Citation>Price MN, Dehal PS, Arkin AP. FastTree 2—approximately maximum-likelihood trees for large alignments. PLoS One. 2010;5:e9490. 10.1371/journal.pone.0009490</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009490</ArticleId><ArticleId IdType="pmc">PMC2835736</ArticleId><ArticleId IdType="pubmed">20224823</ArticleId></ArticleIdList></Reference><Reference><Citation>Burns CC, Shaw J, Jorba J, Bukbuk D, Adu F, Gumede N, et al. Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol. 2013;87:4907–22. 10.1128/JVI.02954-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02954-12</ArticleId><ArticleId IdType="pmc">PMC3624331</ArticleId><ArticleId IdType="pubmed">23408630</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization (WHO). Circulating vaccine-derived poliovirus type 2—global update. 26 March 2021.  [cited 2021 Oct 28]. https://www.who.int/emergencies/disease-outbreak-news/item/circulating-vaccine-derived-poliovirus-type-2-global-update</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. Circulating vaccine-derived polioviruses [cited 2021 Nov 2]. https://polioeradication.org/polio-today/polio-now/this-week/circulating-vaccine-derived-poliovirus</Citation></Reference><Reference><Citation>Alleman MM, Jorba J, Henderson E, Diop OM, Shaukat S, Traoré MA, et al. Update on vaccine-derived poliovirus outbreaks—worldwide, January 2020–June 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1691–9. 10.15585/mmwr.mm7049a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7049a1</ArticleId><ArticleId IdType="pmc">PMC8659190</ArticleId><ArticleId IdType="pubmed">34882653</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes EF, Diop OM, Jorba J, Chavan S, Tangermann RH, Wassilak SG. Surveillance systems to track progress toward polio eradication—worldwide, 2015–2016. MMWR Morb Mortal Wkly Rep. 2017;66:359–65. 10.15585/mmwr.mm6613a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6613a3</ArticleId><ArticleId IdType="pmc">PMC5657908</ArticleId><ArticleId IdType="pubmed">28384129</ArticleId></ArticleIdList></Reference><Reference><Citation>John J, Giri S, Karthikeyan AS, Iturriza-Gomara M, Muliyil J, Abraham A, et al. Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial. Lancet. 2014;384:1505–12. 10.1016/S0140-6736(14)60934-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60934-X</ArticleId><ArticleId IdType="pubmed">25018120</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative. Novel oral polio vaccine type 2 (nOPV2) granted EUL recommendation. 2020.  [cited 2022 Feb 2]. https://polioeradication.org/news-post/novel-oral-polio-vaccine-type-2-nopv2-granted-interim-emergency-use-listing-recommendation</Citation></Reference><Reference><Citation>Van Damme P, De Coster I, Bandyopadhyay AS, Revets H, Withanage K, De Smedt P, et al. The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study. Lancet. 2019;394:148–58. 10.1016/S0140-6736(19)31279-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)31279-6</ArticleId><ArticleId IdType="pmc">PMC6626986</ArticleId><ArticleId IdType="pubmed">31174831</ArticleId></ArticleIdList></Reference><Reference><Citation>UNICEF. Kicking polio out of Senegal. 2022.  Feb 2 [cited 2022 Aug 30]. https://www.unicef.org/senegal/recits/bouter-la-polio-hors-du-s%C3%A9n%C3%A9gal.</Citation></Reference><Reference><Citation>Gumede N, Coulibaly SO, Yahaya AA, Ndihokubwayo JB, Nsubuga P, Okeibunor J, et al. Polio Eradication Initiative (PEI) contribution in strengthening public health laboratories systems in the African region. Vaccine. 2016;34:5164–9. 10.1016/j.vaccine.2016.05.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.05.055</ArticleId><ArticleId IdType="pmc">PMC7115515</ArticleId><ArticleId IdType="pubmed">27646028</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Africa. Malawi declares polio outbreak. 17 February 2022.  [cited 2022 Feb 18]. https://www.afro.who.int/news/malawi-declares-polio-outbreak</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative. ThisWeek. 2022;18:•••
https://polioeradication.org/polio-today/polio-now/this-week
cited 2022 May 20.</Citation></Reference><Reference><Citation>Mohammed A, Tomori O, Nkengasong JN. Lessons from the elimination of poliomyelitis in Africa. Nat Rev Immunol. 2021;21:823–8. 10.1038/s41577-021-00640-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00640-w</ArticleId><ArticleId IdType="pmc">PMC8544186</ArticleId><ArticleId IdType="pubmed">34697501</ArticleId></ArticleIdList></Reference><Reference><Citation>Deressa W, Kayembe P, Neel AH, Mafuta E, Seme A, Alonge O. Lessons learned from the polio eradication initiative in the Democratic Republic of Congo and Ethiopia: analysis of implementation barriers and strategies. BMC Public Health. 2020;20(Suppl 4):1807. 10.1186/s12889-020-09879-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-09879-9</ArticleId><ArticleId IdType="pmc">PMC7747367</ArticleId><ArticleId IdType="pubmed">33339529</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>